ArticleBlood2016

Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.

Rebecca Gardner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.